September 19, 2025

Get In Touch

Cashew Oral Immunotherapy Desensitizes Food Allergy Symptoms, Study Finds

Cashew Oral Immunotherapy Study

Israel: Cashew Oral Immunotherapy Study

In a new study published in the journal Allergy, it was found that cashew oral immunotherapy (OIT) desensitizes the majority of cashew-allergic patients and cross-desensitizes them to pistachio.

Oral immunotherapy is a therapeutic option for people who are allergic to milk, eggs, or peanuts, although research on the efficacy and safety of cashew OIT is lacking. As a result, Arnon Elizur and colleagues undertook this study to assess the efficacy of cashew OIT in reducing allergy symptoms.

A group of 50 cashew-allergic individuals aged 4 years or more were recruited in cashew OIT (target dosage 4000 mg protein) from 4/2016 to 12/2019. Fifteen cashew-allergic individuals who continued to avoid cashews acted as controls. It was discovered that the patient had a pistachio and walnut allergy. Both groups' full desensitization rates and accompanying immunological alterations were studied. Patients who had become completely desensitized to cashew were directed to ingest a dosage of 1200 mg cashew protein for 6 months before being exposed to the maximum amount. Patients with co-allergies to pistachio or walnut were exposed to the nut in question.

Results of the Study

  • At the end of the research, 44 of 50 OIT-treated patients (88%) tolerated a dosage of 4000 mg cashew protein, compared to 0% of controls.
  • 3 more patients were desensitized to 1200 mg cashew protein, and three patients discontinued therapy.
  • For home responses, three patients (6%) received injectable epinephrine.
  • Following therapy, desensitized individuals showed lower SPT, sIgE, basophil reactivity, and higher sIgG4.
  • All pistachio (n = 35) and four of eight walnut co-allergic patients were cross-desensitized to the corresponding nut after cashew desensitization.
  • Following desensitization, all (n = 44) patients who consumed a low cashew dosage for 6 months passed a full-dose cashew OFC.

In conclusion, the findings of this study point out the efficiency of OIT in desensitization of cashew allergy and it can also be followed safely with other food allergy OIT treatment.

Reference

Elizur, A, Appel, MY, Nachshon, L, et al. Cashew oral immunotherapy for desensitizing cashew-pistachio allergy (NUT CRACKER study). Allergy. 2022; 00: 1–10. doi:10.1111/all.15212

Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our Terms of Use, Privacy Policy, and Advertisement Policy.
For further details, please review our Full Disclaimer.

0 Comments

Post a comment

Please login to post a comment.

No comments yet. Be the first to comment!